Alain R. THIERRY
Director of Research at the INSERM in the Institute of Research of Cancerology of Montpellier, France.
Biography
A.R. Thierry is Director of Research at the INSERM in the Institute of Research of Cancerology of Montpellier, France. His research interest focuses on the study of the diagnostic capacity of circulating DNA and the development of methods towards supporting personalised medicine. A.R. Thierry has coordinated a prospective blinded multicentric studies showing the first clinical validation and demonstration of clinical utility of the plasma DNA analysis in oncology, by detecting point mutations in KRAS and BRAF from colorectal patients. He is one of the world leaders in the clinical application of the analysis of circulating DNA and now he is directing various studies on prognosis, cancer patient follow up and cancer screening. He is the principal founder of DiaDx, a Biotech company devoted to liquid biopsy solutions in oncology
Abstract
Abstract : Circulating DNA analysis as the next generation diagnostic in oncology